Pinnacle Wealth Planning Services Inc. Grows Stake in HCA Healthcare, Inc. $HCA

Pinnacle Wealth Planning Services Inc. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 38.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 979 shares of the company’s stock after buying an additional 274 shares during the period. Pinnacle Wealth Planning Services Inc.’s holdings in HCA Healthcare were worth $375,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $27,000. Clearstead Trust LLC boosted its position in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares in the last quarter. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $26,000. Finally, Saudi Central Bank purchased a new position in HCA Healthcare during the first quarter valued at $26,000. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Zacks Research upgraded shares of HCA Healthcare from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 29th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research report on Monday, October 27th. Oppenheimer increased their target price on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. Finally, Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $474.53.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $478.64 on Wednesday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $480.00. The business’s fifty day moving average is $436.04 and its 200 day moving average is $398.67. The stock has a market capitalization of $109.22 billion, a PE ratio of 18.50, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.